Rita M. O'Connor
2017
In 2017, Rita M. O'Connor earned a total compensation of $453.8K as Chief Financial Officer at Dipexium Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $43,995 |
|---|---|
| Option Awards | $253,557 |
| Salary | $150,000 |
| Other | $6,250 |
| Total | $453,802 |
O'Connor received $253.6K in option awards, accounting for 56% of the total pay in 2017.
O'Connor also received $44K in non-equity incentive plan, $150K in salary and $6.3K in other compensation.
Rankings
In 2017, Rita M. O'Connor's compensation ranked 12,194th out of 14,666 executives tracked by ExecPay. In other words, O'Connor earned more than 16.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,194 out of 14,666 | 17th |
Division Manufacturing | 4,798 out of 5,770 | 17th |
Major group Chemicals And Allied Products | 1,757 out of 2,074 | 15th |
Industry group Drugs | 1,457 out of 1,730 | 16th |
Industry Pharmaceutical Preparations | 1,127 out of 1,329 | 15th |
Source: SEC filing on August 10, 2018.
O'Connor's colleagues
We found two more compensation records of executives who worked with Rita M. O'Connor at Dipexium Pharmaceuticals in 2017.